BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1358776)

  • 1. Effect of nicotinic acid on plasma glucose concentration in normal individuals.
    Landau C; Chen YD; Skowronski R; Hollenbeck CB; Jaspan JB; Reaven GM
    Horm Metab Res; 1992 Sep; 24(9):424-8. PubMed ID: 1358776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of plasma NEFA concentration by nicotinic acid enhances the response to insulin in feed-restricted Holstein cows.
    Pires JA; Pescara JB; Grummer RR
    J Dairy Sci; 2007 Oct; 90(10):4635-42. PubMed ID: 17881684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of nicotinic acid to induce sustained low plasma nonesterified fatty acids in feed-restricted Holstein cows.
    Pires JA; Grummer RR
    J Dairy Sci; 2007 Aug; 90(8):3725-32. PubMed ID: 17638983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of insulin on glucose and and fat metabolism in ewes during various reproductive states in normal and hypocalcemia].
    Schlumbohm C; Sporleder HP; Gürtler H; Harmeyer J
    Dtsch Tierarztl Wochenschr; 1997 Sep; 104(9):359-65. PubMed ID: 9410723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pancreatic glucagon and C-peptide secretion during hyperinsulinemia in euglycemic glucose clamp with or without somatostatin infusion in normal man.
    Wu MS; Ho LT
    Horm Metab Res; 1987 Jun; 19(6):253-6. PubMed ID: 2887501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans.
    Carpentier AC; Frisch F; Cyr D; Généreux P; Patterson BW; Giguère R; Baillargeon JP
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E849-56. PubMed ID: 15972273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon does not increase plasma free fatty acid and glycerol concentrations in patients with noninsulin-dependent diabetes mellitus.
    Jeng CY; Sheu WH; Jaspan JB; Polonsky KS; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1993 Jul; 77(1):6-10. PubMed ID: 8100832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ketone bodies on glucose production and utilization in the miniature pig.
    Müller MJ; Paschen U; Seitz HJ
    J Clin Invest; 1984 Jul; 74(1):249-61. PubMed ID: 6376544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of somatostatin in the Syrian hamster bearing a transplantable islet-cell tumor.
    Luyckx AS; Lefebvre PJ
    Horm Metab Res; 1978 Mar; 10(2):105-10. PubMed ID: 206496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of short term physiological elevations of plasma glucagon concentration on plasma triglyceride concentration in normal and diabetic man.
    Schade DS; Eaton RP
    Horm Metab Res; 1977 Jul; 9(4):253-7. PubMed ID: 892688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolic risks of salbutamol in diabetic patients. A study using somatostatin (author's transl)].
    Schlienger JL; Compagnie MJ; Dellenbach P; Stephan F
    Nouv Presse Med; 1980 Sep; 9(32):2247-51. PubMed ID: 6106923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects.
    Nielsen MF; Caumo A; Chandramouli V; Schumann WC; Cobelli C; Landau BR; Vilstrup H; Rizza RA; Schmitz O
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E102-10. PubMed ID: 12965873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in circulating fuels, pancreatic hormones and liver glycogen concentration in fasting or suckling newborn pigs.
    Pégorier JP; Duée PH; Assan R; Peret J; Girard J
    J Dev Physiol; 1981 Jun; 3(3):203-17. PubMed ID: 7040535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of extended-release nicotinic acid on nonesterified fatty acid flux in the metabolic syndrome with atherogenic dyslipidemia.
    Vega GL; Cater NB; Meguro S; Grundy SM
    Am J Cardiol; 2005 Jun; 95(11):1309-13. PubMed ID: 15904634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infusion of nicotinic acid stimulates leucine oxidation and inhibits protein synthesis in pigs before and during a meal.
    Ostaszewski P; Nissen S
    Horm Metab Res; 1988 Mar; 20(3):154-7. PubMed ID: 3290077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity.
    McLaughlin T; Abbasi F; Lamendola C; Kim HS; Reaven GM
    Metabolism; 2001 Jul; 50(7):819-24. PubMed ID: 11436188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output.
    Everett-Grueter C; Edgerton DS; Donahue EP; Vaughan S; Chu CA; Sindelar DK; Cherrington AD
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E449-59. PubMed ID: 16608886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of somatostatin on established induced ketosis.
    Fallucca F; Barbetti F; Maldonato A; Spallone V; Giangrande L; Gambardella S
    Horm Metab Res; 1982 Oct; 14(10):512-5. PubMed ID: 6129185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.